COVID-19 booster dose: Centre in talks with Gennova Biopharmaceuticals to test mRNA vaccine

In the wake of the rising cases of Omicron variant of novel coronavirus, the Union government is in discussion with Pune-based Gennova Biopharmaceuticals Ltd to consider its mRNA vaccine for booster dose.

Gennova’s messenger RNA or mRNA vaccine is in the late-stage trial. It has completed phase 2 studies and has progressed well in the third phase, News18 reported.

Leave a Reply

Your email address will not be published.